The Experience of Surfactant Therapy in Severe COVID-19 Pneumonia: A Case Report
The COVID-19 pandemic has presented challenges to finding effective treatment for lung damage. Medical researchers from different countries recognize the deficiency of pulmonary surfactant (PS) as a significant cause of the alveolar collapse, followed by microatelectasis and severe disturbances in t...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
International Medical Research and Development Corporation
2021-06-01
|
| Series: | International Journal of Biomedicine |
| Subjects: | |
| Online Access: | http://ijbm.org/articles/i42/ijbm_11(2)_cr1.pdf |
| id |
doaj-041993d769744eaa82a8462cf0254c28 |
|---|---|
| record_format |
Article |
| spelling |
doaj-041993d769744eaa82a8462cf0254c282021-06-05T23:50:18ZengInternational Medical Research and Development CorporationInternational Journal of Biomedicine2158-05102158-05292021-06-0111217718010.21103/Article11(2)_CR1The Experience of Surfactant Therapy in Severe COVID-19 Pneumonia: A Case ReportIgor N. Banin0Andrey V. Budnevsky1Vyacheslav I. Grechkin2Evgeniy S. Ovsyannikov3Roman E. Tokmachev4Oleg D. Neznamov5Inessa A. Savushkina6Voronezh City Clinical Emergency Hospital №1, Voronezh, the Russian FederationVoronezh State Medical University named after N. N. Burdenko, Voronezh, the Russian FederationVoronezh State Medical University named after N. N. Burdenko, Voronezh, the Russian FederationVoronezh State Medical University named after N. N. Burdenko, Voronezh, the Russian FederationVoronezh State Medical University named after N. N. Burdenko, Voronezh, the Russian FederationVoronezh City Clinical Emergency Hospital №1, Voronezh, the Russian FederationVoronezh City Clinical Emergency Hospital №1, Voronezh, the Russian FederationThe COVID-19 pandemic has presented challenges to finding effective treatment for lung damage. Medical researchers from different countries recognize the deficiency of pulmonary surfactant (PS) as a significant cause of the alveolar collapse, followed by microatelectasis and severe disturbances in the ventilation-perfusion relationship. Due to the pathophysiological rationale, experimental confirmations, and accumulated clinical experience, the PS preparations can be used to treat patients with severe COVID-19. The article provides a description of a case when ST was successfully used in a patient with severe COVID-19 pneumonia. http://ijbm.org/articles/i42/ijbm_11(2)_cr1.pdfcovid-19pneumoniapulmonary surfactant |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Igor N. Banin Andrey V. Budnevsky Vyacheslav I. Grechkin Evgeniy S. Ovsyannikov Roman E. Tokmachev Oleg D. Neznamov Inessa A. Savushkina |
| spellingShingle |
Igor N. Banin Andrey V. Budnevsky Vyacheslav I. Grechkin Evgeniy S. Ovsyannikov Roman E. Tokmachev Oleg D. Neznamov Inessa A. Savushkina The Experience of Surfactant Therapy in Severe COVID-19 Pneumonia: A Case Report International Journal of Biomedicine covid-19 pneumonia pulmonary surfactant |
| author_facet |
Igor N. Banin Andrey V. Budnevsky Vyacheslav I. Grechkin Evgeniy S. Ovsyannikov Roman E. Tokmachev Oleg D. Neznamov Inessa A. Savushkina |
| author_sort |
Igor N. Banin |
| title |
The Experience of Surfactant Therapy in Severe COVID-19 Pneumonia: A Case Report |
| title_short |
The Experience of Surfactant Therapy in Severe COVID-19 Pneumonia: A Case Report |
| title_full |
The Experience of Surfactant Therapy in Severe COVID-19 Pneumonia: A Case Report |
| title_fullStr |
The Experience of Surfactant Therapy in Severe COVID-19 Pneumonia: A Case Report |
| title_full_unstemmed |
The Experience of Surfactant Therapy in Severe COVID-19 Pneumonia: A Case Report |
| title_sort |
experience of surfactant therapy in severe covid-19 pneumonia: a case report |
| publisher |
International Medical Research and Development Corporation |
| series |
International Journal of Biomedicine |
| issn |
2158-0510 2158-0529 |
| publishDate |
2021-06-01 |
| description |
The COVID-19 pandemic has presented challenges to finding effective treatment for lung damage. Medical researchers from different countries recognize the deficiency of pulmonary surfactant (PS) as a significant cause of the alveolar collapse, followed by microatelectasis and severe disturbances in the ventilation-perfusion relationship. Due to the pathophysiological rationale, experimental confirmations, and accumulated clinical experience, the PS preparations can be used to treat patients with severe COVID-19. The article provides a description of a case when ST was successfully used in a patient with severe COVID-19 pneumonia. |
| topic |
covid-19 pneumonia pulmonary surfactant |
| url |
http://ijbm.org/articles/i42/ijbm_11(2)_cr1.pdf |
| work_keys_str_mv |
AT igornbanin theexperienceofsurfactanttherapyinseverecovid19pneumoniaacasereport AT andreyvbudnevsky theexperienceofsurfactanttherapyinseverecovid19pneumoniaacasereport AT vyacheslavigrechkin theexperienceofsurfactanttherapyinseverecovid19pneumoniaacasereport AT evgeniysovsyannikov theexperienceofsurfactanttherapyinseverecovid19pneumoniaacasereport AT romanetokmachev theexperienceofsurfactanttherapyinseverecovid19pneumoniaacasereport AT olegdneznamov theexperienceofsurfactanttherapyinseverecovid19pneumoniaacasereport AT inessaasavushkina theexperienceofsurfactanttherapyinseverecovid19pneumoniaacasereport AT igornbanin experienceofsurfactanttherapyinseverecovid19pneumoniaacasereport AT andreyvbudnevsky experienceofsurfactanttherapyinseverecovid19pneumoniaacasereport AT vyacheslavigrechkin experienceofsurfactanttherapyinseverecovid19pneumoniaacasereport AT evgeniysovsyannikov experienceofsurfactanttherapyinseverecovid19pneumoniaacasereport AT romanetokmachev experienceofsurfactanttherapyinseverecovid19pneumoniaacasereport AT olegdneznamov experienceofsurfactanttherapyinseverecovid19pneumoniaacasereport AT inessaasavushkina experienceofsurfactanttherapyinseverecovid19pneumoniaacasereport |
| _version_ |
1721395634463834112 |